Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia

Purpose of Review Prevalence of benign prostatic hyperplasia (BPH) is increasing with the aging population worldwide. Knowledge of the natural history of BPH is crucial for primary, secondary and tertiary prevention of its progression. This review examines the evidence of the natural history of BPH, highlighting the group of patients with mild symptoms and the risk factors for progression. Recent findings Several community and clinical studies have demonstrated the progressive nature of BPH. Different surrogate endpoints, which include symptoms score, peak urinary flow rate, prostate volume, and the occurrence of acute urinary retention and need for surgery, have been described. Prostatic specific antigen and prostate volume are the two most common predictors of clinical progression and are helpful to the clinician for identifying high-risk patients. Summary With further understanding of the natural history and the predictors of progression of BPH, management can be tailored according to risk stratification and the results of clinical trials of effectiveness can be better interpreted.